KRAS4A and KRAS4B are the gene products of oncogenicKRASand only differ in the C-terminal membrane targeting region.12Normal cells overexpressing either KRAS4A or KRAS4B can acquire the properties of cancer.13So far, the functional differences between them have not been determined. Here, KRAS is linked to cancer.